Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

32.02

-0.44 (-1.36%)

At close: Dec 5, 2025, 4:00 PM EST

32.00

-0.02 (-0.06%)

After-hours: Dec 5, 2025, 6:05 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Monoclonal Antibody	302.00K	Log In	Log In	Log In	Log In	Upgrade
Monoclonal Antibody Growth	-3.82%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	302.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-3.82%	Log In	Log In	Log In	Log In	Upgrade